Sustainability of Blood Pressure Reduction in Black Barbershops
We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension-certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood p...
Uloženo v:
| Vydáno v: | Circulation (New York, N.Y.) Ročník 139; číslo 1; s. 10 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
02.01.2019
|
| Témata: | |
| ISSN: | 1524-4539, 1524-4539 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension-certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research.
We enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons' primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months.
At baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9-27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group ( P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups.
Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension-certified pharmacists. Broad-scale implementation research is both justified and warranted.
URL: https://www.clinicaltrials.gov . Unique identifier: NCT 02321618. |
|---|---|
| AbstractList | We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension-certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research.BACKGROUNDWe developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension-certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research.We enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons' primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months.METHODSWe enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons' primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months.At baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9-27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group ( P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups.RESULTSAt baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9-27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group ( P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups.Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension-certified pharmacists. Broad-scale implementation research is both justified and warranted.CONCLUSIONSAmong black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension-certified pharmacists. Broad-scale implementation research is both justified and warranted.URL: https://www.clinicaltrials.gov . Unique identifier: NCT 02321618.CLINICAL TRIAL REGISTRATIONURL: https://www.clinicaltrials.gov . Unique identifier: NCT 02321618. We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension-certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research. We enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons' primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months. At baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9-27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group ( P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups. Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension-certified pharmacists. Broad-scale implementation research is both justified and warranted. URL: https://www.clinicaltrials.gov . Unique identifier: NCT 02321618. |
| Author | Elashoff, Robert M Li, Ning Blyler, Ciantel A Lynch, Kathleen Chang, L Cindy Rader, Florian Victor, Ronald G Moy, Norma B Rashid, Mohamad Handler, Joel Brettler, Jeffrey |
| Author_xml | – sequence: 1 givenname: Ronald G surname: Victor fullname: Victor, Ronald G organization: Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, CA (R.G.V., C.A.B., K.L., N.B.M., M.R., F.R.) – sequence: 2 givenname: Ciantel A surname: Blyler fullname: Blyler, Ciantel A organization: Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, CA (R.G.V., C.A.B., K.L., N.B.M., M.R., F.R.) – sequence: 3 givenname: Ning surname: Li fullname: Li, Ning organization: Department of Biomathematics at University of California, Los Angeles, David Geffen School of Medicine (N.L., L.C.C., R.M.E.) – sequence: 4 givenname: Kathleen surname: Lynch fullname: Lynch, Kathleen organization: Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, CA (R.G.V., C.A.B., K.L., N.B.M., M.R., F.R.) – sequence: 5 givenname: Norma B surname: Moy fullname: Moy, Norma B organization: Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, CA (R.G.V., C.A.B., K.L., N.B.M., M.R., F.R.) – sequence: 6 givenname: Mohamad surname: Rashid fullname: Rashid, Mohamad organization: Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, CA (R.G.V., C.A.B., K.L., N.B.M., M.R., F.R.) – sequence: 7 givenname: L Cindy surname: Chang fullname: Chang, L Cindy organization: Department of Biomathematics at University of California, Los Angeles, David Geffen School of Medicine (N.L., L.C.C., R.M.E.) – sequence: 8 givenname: Joel surname: Handler fullname: Handler, Joel organization: Kaiser-Permanente, Los Angeles, CA (J.H., J.B.) – sequence: 9 givenname: Jeffrey surname: Brettler fullname: Brettler, Jeffrey organization: Kaiser-Permanente, Los Angeles, CA (J.H., J.B.) – sequence: 10 givenname: Florian surname: Rader fullname: Rader, Florian organization: Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, CA (R.G.V., C.A.B., K.L., N.B.M., M.R., F.R.) – sequence: 11 givenname: Robert M surname: Elashoff fullname: Elashoff, Robert M organization: Department of Biomathematics at University of California, Los Angeles, David Geffen School of Medicine (N.L., L.C.C., R.M.E.) |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30592662$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUMtKw0AUHaRiH_oLEnduUueRmUlWkga1hWKltuswTxxNM3UmWfTvDVjB1T0vDpw7BaPWtwaAOwTnCDH0UK221X5d7lab13JZDlo-hyRHjF6ACaI4SzNKitE_PAbTGD8hhIxwegXGBNICM4Yn4PG9j51wrZCucd0p8TZZNN7r5C2YGPtgkq3RveqcbxPXDp5QX8lCBGlC_PDHeA0urWiiuTnfGdg_P-2qZbrevKyqcp2qjOVZapiwElNMMCoQtJwIPDDKkbEmkwJrLjUmmlEtFNMFUznPBbSa0oJYLhWegfvf3mPw372JXX1wUZmmEa3xfazx8BcOMYZwiN6eo708GF0fgzuIcKr_RuMfrc9dBw |
| CitedBy_id | crossref_primary_10_3390_jcm13154338 crossref_primary_10_1093_ajh_hpab187 crossref_primary_10_1161_HYPERTENSIONAHA_121_17570 crossref_primary_10_1177_00111287221130956 crossref_primary_10_1055_s_0043_1778639 crossref_primary_10_1161_HYPERTENSIONAHA_119_13542 crossref_primary_10_1016_j_jacc_2022_06_028 crossref_primary_10_1161_HYPERTENSIONAHA_123_21100 crossref_primary_10_1097_HCO_0000000000000674 crossref_primary_10_1016_j_lanwpc_2023_100839 crossref_primary_10_1080_10852352_2024_2408506 crossref_primary_10_1161_JAHA_123_032370 crossref_primary_10_1161_JAHA_120_020796 crossref_primary_10_1007_s40620_022_01516_5 crossref_primary_10_5888_pcd17_200277 crossref_primary_10_1161_JAHA_121_020997 crossref_primary_10_1177_1524839920933897 crossref_primary_10_1007_s11886_022_01826_x crossref_primary_10_3390_pharmacy11030093 crossref_primary_10_1002_jac5_70008 crossref_primary_10_3390_encyclopedia5030133 crossref_primary_10_1161_CIRCULATIONAHA_120_051782 crossref_primary_10_1001_jamapediatrics_2021_1112 crossref_primary_10_1371_journal_pone_0261030 crossref_primary_10_1007_s40615_022_01474_5 crossref_primary_10_1161_JAHA_122_025271 crossref_primary_10_1056_NEJMp1912293 crossref_primary_10_1093_ajh_hpab053 crossref_primary_10_3390_healthcare13121397 crossref_primary_10_1007_s11606_020_05764_8 crossref_primary_10_1097_HCO_0000000000000742 crossref_primary_10_1007_s11886_020_01319_9 crossref_primary_10_1161_CIR_0000000000001096 crossref_primary_10_1016_j_ajpc_2021_100250 crossref_primary_10_4102_safp_v64i1_5434 crossref_primary_10_1016_j_jacc_2019_08_1001 crossref_primary_10_1080_28338073_2023_2269074 crossref_primary_10_1097_HJH_0000000000003480 crossref_primary_10_3390_vaccines12091011 crossref_primary_10_1161_CIRCULATIONAHA_118_038240 crossref_primary_10_1007_s11606_020_06012_9 crossref_primary_10_1016_j_cjca_2024_01_028 crossref_primary_10_1001_jamanetworkopen_2024_21993 crossref_primary_10_1016_j_japh_2024_102217 crossref_primary_10_1038_s41582_023_00921_z crossref_primary_10_1093_ajh_hpab162 crossref_primary_10_1161_STROKEAHA_120_030427 crossref_primary_10_1093_eurheartj_ehae142 crossref_primary_10_1007_s11883_025_01326_7 crossref_primary_10_1161_CIR_0000000000001141 crossref_primary_10_1186_s12889_023_16210_9 crossref_primary_10_1177_15579883231152114 crossref_primary_10_1371_journal_pone_0317815 crossref_primary_10_2147_PPA_S530503 crossref_primary_10_1161_CIRCOUTCOMES_123_009867 crossref_primary_10_1161_HYPERTENSIONAHA_122_20292 crossref_primary_10_1161_CIRCULATIONAHA_120_051683 crossref_primary_10_1161_CIRCHEARTFAILURE_119_006445 crossref_primary_10_1038_s41581_020_00363_6 crossref_primary_10_1161_CIRCULATIONAHA_120_050670 crossref_primary_10_1371_journal_pone_0303075 crossref_primary_10_1016_j_pcad_2019_12_002 crossref_primary_10_1093_ajh_hpz021 crossref_primary_10_1177_15443167221076128 crossref_primary_10_1097_MLR_0000000000001813 crossref_primary_10_1161_HYPERTENSIONAHA_124_20533 crossref_primary_10_1038_s41371_020_0331_7 crossref_primary_10_1155_2019_2470801 crossref_primary_10_1161_CIRCOUTCOMES_120_006780 crossref_primary_10_1186_s12889_021_11584_0 crossref_primary_10_1016_j_vaccine_2025_127606 crossref_primary_10_1016_S0140_6736_21_02252_2 crossref_primary_10_1093_tbm_ibae060 crossref_primary_10_1002_ccd_29751 crossref_primary_10_1007_s11906_019_0996_x crossref_primary_10_1161_JAHA_122_026347 crossref_primary_10_1161_JAHA_121_024785 crossref_primary_10_1093_ajh_hpad009 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1161/CIRCULATIONAHA.118.038165 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1524-4539 |
| ExternalDocumentID | 30592662 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | Los Angeles |
| GeographicLocations_xml | – name: Los Angeles |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL117983 – fundername: NCATS NIH HHS grantid: UL1 TR001881 |
| GroupedDBID | --- .-D .3C .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACOAL ACRKK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADCYY ADGGA ADHPY AE3 AE6 AEBDS AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DU5 E3Z EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH OCB ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ~H1 7X8 AAFWJ ABPXF ABUFD ACBKD ADKSD ADSXY |
| ID | FETCH-LOGICAL-c4684-e6afb252321910f73a2252571efe4ba2d7bd23d65dac6d96c878a0fd5593f7bc2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 88 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00003017-201901020-00004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1524-4539 |
| IngestDate | Sun Nov 09 11:49:10 EST 2025 Thu Apr 03 07:04:41 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | hypertension ethnic groups continental population groups |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4684-e6afb252321910f73a2252571efe4ba2d7bd23d65dac6d96c878a0fd5593f7bc2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.118.038165 |
| PMID | 30592662 |
| PQID | 2161702200 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2161702200 pubmed_primary_30592662 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-01-02 20190102 |
| PublicationDateYYYYMMDD | 2019-01-02 |
| PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-02 day: 02 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Circulation (New York, N.Y.) |
| PublicationTitleAlternate | Circulation |
| PublicationYear | 2019 |
| References | 30592660 - Circulation. 2019 Jan 2;139(1):20-23. doi: 10.1161/CIRCULATIONAHA.118.038240 |
| References_xml | – reference: 30592660 - Circulation. 2019 Jan 2;139(1):20-23. doi: 10.1161/CIRCULATIONAHA.118.038240 |
| SSID | ssj0006375 |
| Score | 2.564593 |
| Snippet | We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 10 |
| SubjectTerms | Adult Aged Antihypertensive Agents - therapeutic use Barbering Black or African American - psychology Blood Pressure - drug effects Community Pharmacy Services - organization & administration Cultural Characteristics Health Knowledge, Attitudes, Practice - ethnology Health Promotion - organization & administration Humans Hypertension - drug therapy Hypertension - ethnology Hypertension - physiopathology Hypertension - psychology Los Angeles Male Middle Aged Patient Acceptance of Health Care - ethnology Pharmacists - organization & administration Professional Role Time Factors Treatment Outcome |
| Title | Sustainability of Blood Pressure Reduction in Black Barbershops |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30592662 https://www.proquest.com/docview/2161702200 |
| Volume | 139 |
| WOSCitedRecordID | wos00003017-201901020-00004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFB7USvHi0rrUjSmIt2iWyczkJLVYKrSlFAu9lcks0INJbVTov_fNJKUnQfCSQyAQ3vq9HaG7OBahlhxiEzeSA5DZS5nwPR4TrYHhiqVuu_6AjUZ8NkvGVcKtqNoqNzbRGWqVS5sjfwwtELdjof7T8sOzV6NsdbU6obGLahFAGSvVbLbdFk4jt2gXXBTxSBwlddR2RoIGj93XSXc6KBfO9jvwjj-4Glr8O9J0Hqd39N9_PUaHFdbEnVI4TtCOzhqo2ckgzn5f43vsuj9dWr2B6sOqyN4E_L4ZqrJ9s2ucG_xs29txOUq40nhi971ajuJFhl0KENu6hW2JzpfFKZr2Xt66fa-6s-BJQjnxNBUmDSEiBesV-IZFApQcVDnQRpNUhMAvFUaKxkpIqhIqOePCNwqCkciwVIZnaC_LM32BMNNEcSoTlqbg9nwG0V0kZKB8ooximrZQe0OxOcixLU6ITOdfxXxLsxY6L8k-X5YLN-ZgkxIAEuHlH76-QgeAaRKXJQmvUc2AFusbtC-_PxfF6tYJCDxH4-EP2K7DCw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sustainability+of+Blood+Pressure+Reduction+in+Black+Barbershops&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Victor%2C+Ronald+G&rft.au=Blyler%2C+Ciantel+A&rft.au=Li%2C+Ning&rft.au=Lynch%2C+Kathleen&rft.date=2019-01-02&rft.issn=1524-4539&rft.eissn=1524-4539&rft.volume=139&rft.issue=1&rft.spage=10&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.118.038165&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4539&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4539&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4539&client=summon |